Heart Failure with Preserved Ejection Fraction: Clinical Characteristics of 4133 Patients Enrolled in the I-PRESERVE Trial

Abstract

Patients in I-PRESERVE are broadly representative of those seen in epidemiological studies and, because of this, the results of this trial should be generally applicable to "real world" patients with heart failure and preserved ejection fraction.